TR
Thanyanan Reungwetwattana
Specialist
Credentials: ·
Research
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · 4,542 citations
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
New England Journal of Medicine · 2020 · 2,483 citations
Journal of Clinical Oncology · 2018 · First of 18 authors · 711 citations
9 papers
4 papers
4 papers
3 papers
3 papers
- KL
3 papers
- PD
3 papers
- SO
3 papers
